Defense Secretary Pete Hegseth announced a new plan to offer military personnel aged 30 and older annual testosterone testing, with optional hormone injections for those with low levels. Hegseth stated the program aims to optimize warfighters’ natural capabilities by addressing age-related declines. However, the initiative immediately drew widespread criticism and mockery on social media, with many pointing out the perceived hypocrisy given past actions regarding gender-affirming care for transgender service members. Critics also derided the timing of the announcement amidst ongoing global conflicts.
Read the original article here
The recent proposal to offer testosterone to U.S. soldiers, framed by some as “literally gender-affirming care,” has ignited a firestorm of criticism and mockery, particularly directed at Pete Hegseth, the individual reportedly behind the idea. This plan, suggesting that supplementing soldiers with testosterone is akin to gender-affirming care, has struck many as a bizarre and even homophobic attempt to gain attention, diverting focus from more pressing matters like legislative hearings. It’s being viewed as a classic tactic from certain political circles: create a sensational headline, spark outrage, and distract from less palatable policies being advanced in the background.
The military is already grappling with significant recruitment challenges, with a substantial portion of the population deemed physically unfit for service. The notion of screening out more potential recruits or focusing on an “alpha male” ideal through testosterone supplementation seems counterintuitive to strengthening the armed forces. Instead of addressing fundamental issues like physical readiness, this proposal appears rooted in a specific political ideology that fetishizes hyper-masculinity and views testosterone as a panacea for male weakness. There’s a perception that this idea stems from a personal obsession with masculinity and potentially even a deeper psychological fixation.
What’s particularly striking is the apparent contradiction with the stated positions of many who champion this idea. The very same groups that often express strong opposition to gender-affirming care for transgender individuals are now seemingly advocating for a form of hormone therapy for cisgender men in the military. This stark hypocrisy has not gone unnoticed. The irony is palpable: arguing that transgender individuals shouldn’t serve due to the perceived medical complexities of hormone therapy, while simultaneously proposing hormone supplementation for cisgender soldiers.
Beyond the political hypocrisy, the health implications of unnecessary testosterone supplementation are a serious concern. Medical professionals have highlighted potential side effects such as heart attacks, blood clots, liver disease, shrinking testicles, infertility, and prostate enlargement. This plan could inadvertently lead to degrading military readiness rather than enhancing it. The idea that this is a necessary medical intervention for the vast majority of soldiers is also being questioned, with claims that clinically low testosterone levels are rare and not routinely tested for, suggesting this is more about a performance of masculinity than genuine medical need.
There’s a concern that such a program would foster insecurity among soldiers, leading them to compare testosterone levels and feel inadequate, potentially demanding supplementation even when medically unnecessary. This could transform military medical discourse into something akin to a quest for peak alpha-male status, rather than focusing on overall health and well-being. It’s also being pointed out that higher testosterone levels are not universally beneficial, with links to impaired judgment, impulsivity, and cognitive deficits. The push for this could be seen as a dangerous experiment, potentially creating soldiers with compromised decision-making abilities.
Furthermore, the very definition of gender-affirming care, as recognized by organizations like the World Health Organization, involves supporting and affirming an individual’s gender identity when it conflicts with their assigned sex at birth. Offering testosterone to cisgender men, particularly without a clear medical diagnosis of deficiency and symptoms, does not align with this definition. It’s being characterized as a misapplication of terminology, used for rhetorical effect rather than accurate representation.
The proposal also raises questions about equity. If cisgender men are to receive hormone therapy, should women in the military also have access to hormone therapies, such as estrogen, for their well-being? The selective application of hormone treatments appears inconsistent and raises concerns about fairness and medical necessity. The suggestion that this is somehow related to an “equity and inclusion” initiative, by bringing those with naturally lower testosterone levels up to a perceived “alpha” standard, seems a twisted interpretation of these concepts.
There’s also an underlying suspicion about the motivations behind such a proposal. Some speculate it’s driven by a personal fascination with hyper-masculinity, perhaps even a projection of personal insecurities or desires, leading to an unhealthy obsession with male virility. The context of certain political figures associating with individuals known for promoting extreme masculinity further fuels these interpretations. The notion of “gender-affirming care” being applied to cisgender men in this manner is seen as a cynical attempt to reframe a potentially harmful policy under a progressive-sounding banner, while fundamentally being about something else entirely.
Ultimately, the proposal to offer testosterone to U.S. soldiers, whether framed as “literally gender-affirming care” or not, is being widely criticized as misguided, potentially harmful, and politically motivated. It appears to be a move designed to provoke rather than to genuinely improve the health or readiness of the military, and in doing so, it has largely succeeded in drawing derision and exposing a perceived ideological agenda.
